If you liked this article you might like

Politicians Question EpiPen Competitor's High Pricetag
Biotech Premarket Movers: Impax, Clearside Biomedical, Mylan
CVS Remains Unsure About the Future of Obamacare, CEO Says
Mylan's Shares Rise Despite FTC Investigation